Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Talking it out: new program aims to cut drug use and HIV in young gay couples

NCT ID NCT03396367

Disease control Sponsor: Hunter College of City University of New York Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a 4-session program called PARTNER for young men who have sex with men (ages 18-29) and are in a relationship. The program uses motivational interviewing and video exercises to improve communication about drug use, PrEP (HIV prevention pills), and safer sex. 196 participants were compared to those who received standard health education. The goal was to see if the program could reduce drug use and HIV transmission risk.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Behavioral intervention (PARTNER: motivational interviewing and video-based communication skills training)
What this could lead to
If successful, this approach could help young men in relationships reduce drug use and improve HIV prevention practices.
What could go wrong
This is a small, completed trial with no phase designation, so results may not apply broadly. The intervention relies on self-reported outcomes, which can be unreliable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

196 people

The number who actually took part.

Started

Feb 2018

Finished

Feb 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 29 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 to 29 years of age (inclusive); * Main partner must be aged 18 or older. * Must be in a main partner relationship with another male (duration ≥ 1 months); * HIV-negative serostatus (confirmed by rapid test); * Recent (past 30 day) use of at least one of the substances identified as most commonly used by YMSM (marijuana, cocaine, methamphetamine, heroin or other opiates, MDMA, psychedelics, GHB, and/or ketamine); * Sexual behavior meeting CDC criteria for PrEP candidacy (TRB with a casual partner in the past 30 days or TRB with a non-monogamous or serodiscordant main partner). * Participants must reside in the NYC metro area * Ability to communicate in English Exclusion Criteria: * Unstable, serious psychiatric symptoms (assessed by the Psychotic Disorder subsection of the Structured Clinical Interview for DSM-IV); * Current suicidal/homicidal ideation; * Evidence of gross cognitive impairment (a score of \<24 on the mini-mental state examination) * A history of severe physical or sexual Intimate Partner Violence (IPV) victimization in the current relationship in which participants report not currently feeling "safe" in their relationship and/or coerced to participate in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adherence, medication are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

AIDS Medication Adherence Risk Reduction Behavior Sexual Behavior substance abuse HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adherence, medication Drug use HIV/AIDS Risk reduction Sex, anal

Contacts and locations

Locations

  • Hunter College- City University of New York

    New York, New York, 10018, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.